Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects - Top-Institutions - MDSpire

Elevated Serum TFF3 Levels in Patients with Gastric Cancer: A Hepatic Source Investigation

  • By

  • Komei Kuge

  • Junko Mukoyama

  • Yoshimi Yasukawa

  • Yuko Ishibashi

  • Hiroki Masuda

  • Tomohiko Yasuda

  • Yasukazu Ohmoto

  • Hideyuki Takeshima

  • Akihisa Matsuda

  • Hiroshi Yoshida

  • Yasuyuki Seto

  • James R. Goldenring

  • Toshikazu Ushijima

  • Sachiyo Nomura

  • July 20, 2026

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Tokyo
    The University of Tokyo

    Tokyo, Tokyo

    Key Differentiators

    • Gastroenterology

  • #2

    National Institute of Health Sciences, Japan
    National Institute of Health Sciences, Japan

    Tokyo, Tokyo

    Key Differentiators

    • Gastroenterology

  • #3

    Ruijin Hospital
    Ruijin Hospital

    Shanghai, Shanghai

    Key Differentiators

    • Gastroenterology

Original Source(s)

Hepatic origin of increased serum TFF3 in gastric cancer bearing subjects

  • by Komei Kuge, Junko Mukoyama, Yoshimi Yasukawa, Yuko Ishibashi, Hiroki Masuda, Tomohiko Yasuda, Yasukazu Ohmoto, Hideyuki Takeshima, Akihisa Matsuda, Hiroshi Yoshida, Yasuyuki Seto, James R. Goldenring, Toshikazu Ushijima, Sachiyo Nomura

  • July 20, 2026

Related Content

Impact of high-fat Western diet on chronic lymphocytic leukemia disease progression and gut microbiome profile in Eµ-TCL1 mice

Treatment patterns and outcomes of patients with a diagnosis of metastatic pancreatic adenocarcinoma in the United States, 2019–2024

The Secrets of the Gut

Going beyond the gut: why microbiome testing is the next big thing in drug development